Clinical Study | Office of Clinical Research

A Phase 3 Randomized, Multicenter, Multinational, Double-Blinded Study Comparing The Efficacy And Safety Of Repeated Biweekly Infusions Of Neogaa (Gz4

Posted Date: May 15, 2019

Investigator: Hani Kushlaf
Type of Study: Drug

The purpose of this study is to evaluate the possible risks and efficacy (improvement of disease), as well as pharmacokinetics (breakdown, use and removal from the body of the study drug (neoGAA) of the study drug (neoGAA) compared to Myozyme?/Lumizyme? (alglucosidase alfa) in the treatment of patie

Criteria:

To Be Considered For This Study, You Must Have Been Diagnosed With Late Onset Pompe Disease (Acid A

Keywords:

Abnormal Emg, Myopathy, Pompe, Elevated Liver Enzym, Enzyme Replacement T

For More Information:

Molly Winters
513-558-0269
molly.winters@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List